REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
06/13/2026
Back to search
Official data from USPTO
ERYTECH
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
ERYTECH
ST13
US500000086966163Class
5, 7, 9, 10, 42, 44
Filing
86966163
Registration
5221059
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
25
Latest update
06/14/2026
Trademark type
Word
Nice classes
5, 7, 9, 10, 42, 44
Filing date
04/06/2016
Registration date
06/13/2017
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/21/2023
Last transaction
06/14/2026
Responsible office
United States Patent and Trademark Office
Status code
704
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
4
Owner type
99
Owner location
Lyon, FR
Examiner
JACKSON, STEVEN W
Law office
L70
Holders and representatives
Holders
E. P. (pessoa física)
Representatives
JANET G RICCIUTI JANET GILBERT RICCIUTI, PC
Technical classification
Nice Classes
Class 5Class 7Class 9Class 10Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the prevention and treatment of cancerblood diseases and disordersmetabolic disordersgenetic rare diseases and immunological condition ; Diagnostic preparations for medical purposesveterinary preparations for treatment of cancer and blood diseases and disordersmetabolic disordersgenetic rare diseases and immunological condition in horsescattledogs and cats; chemical preparations for medical or pharmaceutical usefor the prevention and treatment of cancerblood diseases and disordersmetabolic disordersgenetic rare diseases and immunological condition
Class 7
Machines for the development and/or production of pharmaceutical products or diagnostic products for the prevention and treatment of cancerblood diseases and disordersmetabolic disordersgenetic rare diseases and immunological condition
Class 9
Scientific apparatus and instruments for the development and/or production of pharmaceutical products or diagnostic products for the prevention and treatment of cancerblood diseases and disordersmetabolic disordersgenetic rare diseases and immunological condition
Class 10
Medical apparatus and instruments for use in the prevention and treatment of cancerblood diseases and disordersmetabolic disordersgenetic rare diseases and immunological conditions
Class 42
Evaluationsestimates and research in the scientific and technological fields provided by engineersmaterials testing and evaluationpharmaceutical product evaluationscientific researchtechnology research in the field of scientific equipment. Research and development of new products
Class 44
Medical services
Publications
History of USPTO decisions and trademark events.
25 publications found
NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
10/21/2023
8.PR
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED
10/21/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10/21/2023
ES8R
TEAS SECTION 8 RECEIVED
06/13/2023
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
06/13/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
06/13/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/28/2017
PUBO
PUBLISHED FOR OPPOSITION
03/28/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/08/2017
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
02/22/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/13/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/09/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/09/2017
ALIE
ASSIGNED TO LIE
02/08/2017
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/25/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/25/2017
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/24/2017
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/24/2017
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/25/2016
GNRT
NON-FINAL ACTION E-MAILED
07/25/2016
CNRT
NON-FINAL ACTION WRITTEN
07/25/2016
DOCK
ASSIGNED TO EXAMINER
07/21/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/11/2016
NWAP
NEW APPLICATION ENTERED
04/09/2016
Continuous trademark protection
Get notified about every new filing that threatens ERYTECH or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.